Supreme Cannabis’ premium wellness brand, Blissco, receives oil sales license from Health Canada.
Blissco expects to ship first CBD oil product to the Canadian market in Q2 fiscal 2020.
Blissco product sales expected to meaningfully contribute … Read
Achieves first positive Adjusted EBITDA1 quarter of $3.2 million.
Q4 2019 net revenue was $19 million, a 90% increase from Q3 2019 ($10 million).
Fiscal 2019 total revenue was $41.8 million, a 370% increase from fiscal … Read
7ACRES launches new proprietary premium strain, Jack Haze.
Jack Haze is 7ACRES’ first sativa-dominant strain with rare sensory characteristics.
7ACRES continues to achieve premium pricing with the launch of Jack Haze.
TORONTO, Aug. 13, 2019 /CNW/ – The Supreme Cannabis Company, Inc.(“Supreme Cannabis” or the “Company”) (TSX:FIRE) (OTCQX:SPRWF) (FRA: 53S1) is pleased to announce the closing of its acquisition of all of the issued and outstanding …
Anticipates net revenue of approximately $19 million and positive Adjusted EBITDA1 for Q4 2019.
Forecasts net revenue for fiscal 2020 to be between $150 million and $180 million, and positive Adjusted EBITDA1for fiscal 2020.
The Company … Read
Truverra’s Health Canada licensed facility in Toronto, ON to produce cannabis derivative products for Legalization 2.0.
Truverra to serve as Supreme Cannabis’ global medical brand, building on existing R&D platform and established CBD offering in Europe. … Read